(Ti,Mo)C, TiB2, and Mo2B particles reinforced Fe-based composite coatings were fabricated by laser cladding process. The effects of Molybdenum (Mo) on the microstructure and wear properties of the coatings were investigated. The results show that block-like or cuboidal TiB2, Mo2B and flower-like (Ti, Mo)C ceramics reinforcements were formed in the coatings. The size of reinforcements reduced with the increasing of FeMo70. However, cracks were found in the coating, while the addition of FeMo70 exceeded 9 wt %. The laser cladding coating presented a good wear resistance with a 9 wt % addition of FeMo70. With the increasing of FeMo70, the coatings enhanced the capability of resisting microcutting, microplowing, and surface plastic deformation.
In-situ TiN ceramic particle reinforced FeCoNiCrMnTi high entropy alloy coating was fabricated by laser cladding processing at high purity nitrogen gas atmosphere on the AISI 304 stainless steel substrate. The effect of Ti addition on the microstructure, phase structure and wear properties of the coatings were investigated. The results showed that phase structure of the coatings were mainly FCC-type γ phase. A few of cubic or flower-like TiN ceramic were formed after adding titanium into the FeCoNiCrMn powder. When atomic ratio of Ti exceeds 0.5, Laves phases appeared in the coatings. With increasing of Ti, the micro-hardness and wear resistance of the coatings increased, but friction coefficient and crack resistance of the coatings reduced. Suitable Ti content in the FeCoNiCrMnTix, laser composite coating had higher resistance to adhesive wear, oxidation wear and cracking resistance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.